scientifyRESEARCH
research funding database

RESEARCH FUNDING

CRI Clinical Innovator (cancer immunotherapy clinical trials worldwide)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The CRI Clinical Innovator funding program from the Cancer Research Institute supports novel clinical studies that address areas of high unmet need in cancer and seek mechanistic insights into clinical response with a goal of predictive biomarker discovery. The program supports clinician-scientists aiming to launch innovative phase I/II or phase II clinical studies using novel immunotherapies. Applicants may be based at non-profit research institutions worldwide. Applicants may apply for up to 1 million USD.

Letters of intent are due December 1, 2023. Full invited applications are due on May 1, 2024.

Full application due:
May 1, 2024

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.